These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7605581)

  • 1. Abnormalities of the RB1 and DCC tumor suppressor genes: uncommon in human pancreatic adenocarcinoma.
    Barton CM; McKie AB; Hogg A; Bia B; Elia G; Phillips SM; Ding SF; Lemoine NR
    Mol Carcinog; 1995 Jun; 13(2):61-9. PubMed ID: 7605581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.
    Cawkwell L; Lewis FA; Quirke P
    Br J Cancer; 1994 Nov; 70(5):813-8. PubMed ID: 7947085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
    Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.
    Ruggeri B; Zhang SY; Caamano J; DiRado M; Flynn SD; Klein-Szanto AJ
    Oncogene; 1992 Aug; 7(8):1503-11. PubMed ID: 1630814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral adrenocortical carcinoma showing loss of heterozygosity at the p53 and RB gene loci.
    Miyamoto H; Kubota Y; Shuin T; Shiozaki H
    Cancer Genet Cytogenet; 1996 Jun; 88(2):181-3. PubMed ID: 8640732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma.
    Simon B; Weinel R; Höhne M; Watz J; Schmidt J; Körtner G; Arnold R
    Gastroenterology; 1994 Jun; 106(6):1645-51. PubMed ID: 8194712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and loss of heterozygosity of DCC gene in human lung cancer].
    Zhang J; Ding F; Wang X
    Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):211-3, 254-5. PubMed ID: 7788550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor gene allelic loss in human renal cancers.
    Brooks JD; Bova GS; Marshall FF; Isaacs WB
    J Urol; 1993 Oct; 150(4):1278-83. PubMed ID: 8371415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.
    Chang KW; Laconi S; Mangold KA; Hubchak S; Scarpelli DG
    Cancer Res; 1995 Jun; 55(12):2560-8. PubMed ID: 7780969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the tumor suppressor genes p53, RB, p16/MTS1, and p15/MTS2 in human pancreatic cancer and hepatoma cell lines.
    Kaino M
    J Gastroenterol; 1997 Feb; 32(1):40-6. PubMed ID: 9058294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced or absent expression and codon 201Gly/Arg polymorphism of DCC gene in rhabdomyosarcoma and Ewing's sarcoma/PNET family.
    Choi SH; Kong XT; Taki T; Tsuchida Y; Kawaguchi H; Kato H; Hanada R; Look AT; Hayashi Y
    Int J Mol Med; 2000 Oct; 6(4):463-7. PubMed ID: 10998440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoblastoma gene mutations in primary human prostate cancer.
    Kubota Y; Fujinami K; Uemura H; Dobashi Y; Miyamoto H; Iwasaki Y; Kitamura H; Shuin T
    Prostate; 1995 Dec; 27(6):314-20. PubMed ID: 7501543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular genetics of human pancreatic cancer].
    Villanueva A; Capellá G; Mangues R; Farré A; Lluís F
    Gastroenterol Hepatol; 1999 Nov; 22(9):444-50. PubMed ID: 10638042
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
    Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
    Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract.
    Enomoto T; Fujita M; Cheng C; Nakashima R; Ozaki M; Inoue M; Nomura T
    Br J Cancer; 1995 Mar; 71(3):462-7. PubMed ID: 7880725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
    Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
    Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
    Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
    J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the retinoblastoma gene in human prostate adenocarcinoma.
    Tricoli JV; Gumerlock PH; Yao JL; Chi SG; D'Souza SA; Nestok BR; deVere White RW
    Genes Chromosomes Cancer; 1996 Feb; 15(2):108-14. PubMed ID: 8834174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.